PMID- 30648193 OWN - NLM STAT- MEDLINE DCOM- 20200218 LR - 20200401 IS - 1432-0428 (Electronic) IS - 0012-186X (Print) IS - 0012-186X (Linking) VI - 62 IP - 4 DP - 2019 Apr TI - Maternal glucose levels during pregnancy and childhood adiposity in the Hyperglycemia and Adverse Pregnancy Outcome Follow-up Study. PG - 598-610 LID - 10.1007/s00125-018-4809-6 [doi] AB - AIMS/HYPOTHESIS: Maternal type 2 diabetes during pregnancy and gestational diabetes are associated with childhood adiposity; however, associations of lower maternal glucose levels during pregnancy with childhood adiposity, independent of maternal BMI, remain less clear. The objective was to examine associations of maternal glucose levels during pregnancy with childhood adiposity in the Hyperglycemia and Adverse Pregnancy Outcome (HAPO) cohort. METHODS: The HAPO Study was an observational epidemiological international multi-ethnic investigation that established strong associations of glucose levels during pregnancy with multiple adverse perinatal outcomes. The HAPO Follow-up Study (HAPO FUS) included 4832 children from ten HAPO centres whose mothers had a 75 g OGTT at ~28 weeks gestation 10-14 years earlier, with glucose values blinded to participants and clinical caregivers. The primary outcome was child adiposity, including: (1) being overweight/obese according to sex- and age-specific cut-offs based on the International Obesity Task Force (IOTF) criteria; (2) IOTF-defined obesity only; and (3) measurements >85th percentile for sum of skinfolds, waist circumference and per cent body fat. Primary predictors were maternal OGTT and HbA(1c) values during pregnancy. RESULTS: Fully adjusted models that included maternal BMI at pregnancy OGTT indicated positive associations between maternal glucose predictors and child adiposity outcomes. For one SD difference in pregnancy glucose and HbA(1c) measures, ORs for each child adiposity outcome were in the range of 1.05-1.16 for maternal fasting glucose, 1.11-1.19 for 1 h glucose, 1.09-1.21 for 2 h glucose and 1.12-1.21 for HbA(1c). Associations were significant, except for associations of maternal fasting glucose with offspring being overweight/obese or having waist circumference >85th percentile. Linearity was confirmed in all adjusted models. Exploratory sex-specific analyses indicated generally consistent associations for boys and girls. CONCLUSIONS/INTERPRETATION: Exposure to higher levels of glucose in utero is independently associated with childhood adiposity, including being overweight/obese, obesity, skinfold thickness, per cent body fat and waist circumference. Glucose levels less than those diagnostic of diabetes are associated with greater childhood adiposity; this may have implications for long-term metabolic health. FAU - Lowe, William L Jr AU - Lowe WL Jr AD - Department of Medicine, Northwestern University Feinberg School of Medicine, Chicago, IL, 60611, USA. FAU - Lowe, Lynn P AU - Lowe LP AD - Department of Preventive Medicine, Northwestern University Feinberg School of Medicine, Chicago, IL, USA. FAU - Kuang, Alan AU - Kuang A AD - Department of Preventive Medicine, Northwestern University Feinberg School of Medicine, Chicago, IL, USA. FAU - Catalano, Patrick M AU - Catalano PM AD - MetroHealth Medical Center, Cleveland, OH, USA. AD - Nutrition Obesity Research Center, School of Medicine, Case Western Reserve University, Cleveland, OH, USA. FAU - Nodzenski, Michael AU - Nodzenski M AD - Department of Preventive Medicine, Northwestern University Feinberg School of Medicine, Chicago, IL, USA. FAU - Talbot, Octavious AU - Talbot O AD - Department of Preventive Medicine, Northwestern University Feinberg School of Medicine, Chicago, IL, USA. FAU - Tam, Wing-Hung AU - Tam WH AD - Department of Obstetrics and Gynaecology, The Chinese University of Hong Kong, Hong Kong, China. AD - Prince of Wales Hospital, Hong Kong, China. FAU - Sacks, David A AU - Sacks DA AD - Kaiser Permanente Southern California, Pasadena, CA, USA. FAU - McCance, David AU - McCance D AD - Royal Victoria Hospital, Belfast, UK. FAU - Linder, Barbara AU - Linder B AD - National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK), National Institutes of Health, Bethesda, MD, USA. FAU - Lebenthal, Yael AU - Lebenthal Y AD - Schneider Children's Medical Center of Israel, Petah-Tiqva, Israel. AD - Sackler Faculty of Medicine, Tel Aviv University, Tel Aviv, Israel. FAU - Lawrence, Jean M AU - Lawrence JM AD - Kaiser Permanente Southern California, Pasadena, CA, USA. FAU - Lashley, Michele AU - Lashley M AD - School of Clinical Medicine and Research, Queen Elizabeth Hospital, University of the West Indies, St Michael, Barbados. FAU - Josefson, Jami L AU - Josefson JL AD - Department of Pediatrics, Northwestern University Feinberg School of Medicine, Chicago, IL, USA. AD - Ann and Robert H Lurie Children's Hospital, Chicago, IL, USA. FAU - Hamilton, Jill AU - Hamilton J AD - The Hospital for Sick Children, University of Toronto, Toronto, ON, Canada. FAU - Deerochanawong, Chaicharn AU - Deerochanawong C AD - Rajavithi Hospital, Bangkok, Thailand. FAU - Clayton, Peter AU - Clayton P AD - Royal Manchester Children's Hospital, Royal Manchester University Hospitals, NHS Foundation Trust, Manchester, UK. AD - Manchester Academic Health Sciences Centre, School of Medical Sciences, Faculty of Biology, Medicine & Health, University of Manchester, Manchester, UK. FAU - Brickman, Wendy J AU - Brickman WJ AD - Department of Pediatrics, Northwestern University Feinberg School of Medicine, Chicago, IL, USA. AD - Ann and Robert H Lurie Children's Hospital, Chicago, IL, USA. FAU - Dyer, Alan R AU - Dyer AR AD - Department of Preventive Medicine, Northwestern University Feinberg School of Medicine, Chicago, IL, USA. FAU - Scholtens, Denise M AU - Scholtens DM AD - Department of Preventive Medicine, Northwestern University Feinberg School of Medicine, Chicago, IL, USA. FAU - Metzger, Boyd E AU - Metzger BE AD - Department of Medicine, Northwestern University Feinberg School of Medicine, Chicago, IL, 60611, USA. bem@northwestern.edu. CN - HAPO Follow-up Study Cooperative Research Group LA - eng GR - U01 DK094830/DK/NIDDK NIH HHS/United States GR - UL1 TR001422/TR/NCATS NIH HHS/United States GR - UL1 TR002548/TR/NCATS NIH HHS/United States PT - Journal Article PT - Multicenter Study PT - Observational Study PT - Research Support, N.I.H., Extramural DEP - 20190115 PL - Germany TA - Diabetologia JT - Diabetologia JID - 0006777 RN - 0 (Blood Glucose) SB - IM MH - *Adiposity MH - Adult MH - Blood Glucose/*analysis MH - Body Mass Index MH - Child MH - Diabetes, Gestational/*blood MH - Female MH - Follow-Up Studies MH - Glucose Tolerance Test MH - Humans MH - Hyperglycemia/*blood MH - Male MH - Maternal Age MH - Overweight MH - Pediatric Obesity/*physiopathology MH - Pregnancy MH - Pregnancy Complications MH - Pregnancy Outcome MH - Pregnancy in Diabetics/*blood MH - Prenatal Exposure Delayed Effects/*blood/physiopathology MH - Waist Circumference PMC - PMC6421132 MID - NIHMS1518795 OTO - NOTNLM OT - Adiposity OT - Childhood obesity OT - Glucose OT - Pregnancy EDAT- 2019/01/17 06:00 MHDA- 2020/02/19 06:00 PMCR- 2020/04/01 CRDT- 2019/01/17 06:00 PHST- 2018/09/21 00:00 [received] PHST- 2018/12/12 00:00 [accepted] PHST- 2019/01/17 06:00 [pubmed] PHST- 2020/02/19 06:00 [medline] PHST- 2019/01/17 06:00 [entrez] PHST- 2020/04/01 00:00 [pmc-release] AID - 10.1007/s00125-018-4809-6 [pii] AID - 10.1007/s00125-018-4809-6 [doi] PST - ppublish SO - Diabetologia. 2019 Apr;62(4):598-610. doi: 10.1007/s00125-018-4809-6. Epub 2019 Jan 15.